A citation-based method for searching scientific literature

Xuesen Zhao, Fang Guo, Fei Liu, Andrea Cuconati, Jinhong Chang, Timothy M Block, Ju-Tao Guo. Proc Natl Acad Sci U S A 2014
Times Cited: 106







List of co-cited articles
1214 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
401
56

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
879
38

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
222
37

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
245
34

Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Xuesen Zhao, Mohit Sehgal, Zhifei Hou, Junjun Cheng, Sainan Shu, Shuo Wu, Fang Guo, Sylvain J Le Marchand, Hanxin Lin, Jinhong Chang,[...]. J Virol 2018
59
57

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
30

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
505
29

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
187
29

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
149
27

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
121
27

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
215
25


The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
272
23

Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
86
26

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
121
23

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
158
22

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Tsai-Yu Lin, Christopher R Chin, Aaron R Everitt, Simon Clare, Jill M Perreira, George Savidis, Aaron M Aker, Sinu P John, David Sarlah, Erick M Carreira,[...]. Cell Rep 2013
72
30

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Jessica M Weidner, Dong Jiang, Xiao-Ben Pan, Jinhong Chang, Timothy M Block, Ju-Tao Guo. J Virol 2010
221
22

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Jacob S Yount, Bruno Moltedo, Yu-Ying Yang, Guillaume Charron, Thomas M Moran, Carolina B López, Howard C Hang. Nat Chem Biol 2010
253
21

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Wenhui Li, Michael J Moore, Natalya Vasilieva, Jianhua Sui, Swee Kee Wong, Michael A Berne, Mohan Somasundaran, John L Sullivan, Katherine Luzuriaga, Thomas C Greenough,[...]. Nature 2003
20

The broad-spectrum antiviral functions of IFIT and IFITM proteins.
Michael S Diamond, Michael Farzan. Nat Rev Immunol 2013
453
20


IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
124
20

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
258
19

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, Tristan X Jordan, Kohei Oishi, Maryline Panis, David Sachs,[...]. Cell 2020
19

IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.
Rajini Mudhasani, Julie P Tran, Cary Retterer, Sheli R Radoshitzky, Krishna P Kota, Louis A Altamura, Jeffrey M Smith, Beverly Z Packard, Jens H Kuhn, Julie Costantino,[...]. J Virol 2013
86
20


A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
18

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
Jingyou Yu, Minghua Li, Jordan Wilkins, Shilei Ding, Talia H Swartz, Anthony M Esposito, Yi-Min Zheng, Eric O Freed, Chen Liang, Benjamin K Chen,[...]. Cell Rep 2015
104
18

IFITM3 requires an amphipathic helix for antiviral activity.
Nicholas M Chesarino, Alex A Compton, Temet M McMichael, Adam D Kenney, Lizhi Zhang, Victoria Soewarna, Matthew Davis, Olivier Schwartz, Jacob S Yount. EMBO Rep 2017
53
32

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.
Cody J Warren, Laura M Griffin, Alexander S Little, I-Chueh Huang, Michael Farzan, Dohun Pyeon. PLoS One 2014
53
30

Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.
Amanda A Anafu, Christopher H Bowen, Christopher R Chin, Abraham L Brass, Geoffrey H Holm. J Biol Chem 2013
77
20

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
136
16

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
63
25

The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
Sumudu K Narayana, Karla J Helbig, Erin M McCartney, Nicholas S Eyre, Rowena A Bull, Auda Eltahla, Andrew R Lloyd, Michael R Beard. J Biol Chem 2015
76
21

TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
Stephanie Bertram, Ronald Dijkman, Matthias Habjan, Adeline Heurich, Stefanie Gierer, Ilona Glowacka, Kathrin Welsch, Michael Winkler, Heike Schneider, Heike Hofmann-Winkler,[...]. J Virol 2013
177
15

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
15

Opposing activities of IFITM proteins in SARS-CoV-2 infection.
Guoli Shi, Adam D Kenney, Elena Kudryashova, Ashley Zani, Lizhi Zhang, Kin Kui Lai, Luanne Hall-Stoodley, Richard T Robinson, Dmitri S Kudryashov, Alex A Compton,[...]. EMBO J 2021
62
24

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.
Dong Jiang, Jessica M Weidner, Min Qing, Xiao-Ben Pan, Haitao Guo, Chunxiao Xu, Xianchao Zhang, Alex Birk, Jinhong Chang, Pei-Yong Shi,[...]. J Virol 2010
248
14

Interferon-induced transmembrane protein 3 is a type II transmembrane protein.
Charles C Bailey, Hema R Kondur, I-Chueh Huang, Michael Farzan. J Biol Chem 2013
62
22

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
87
16

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Toshana L Foster, Harry Wilson, Shilpa S Iyer, Karen Coss, Katie Doores, Sarah Smith, Paul Kellam, Andrés Finzi, Persephone Borrow, Beatrice H Hahn,[...]. Cell Host Microbe 2016
109
14

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.
Xuesen Zhao, Jiarui Li, Cheryl A Winkler, Ping An, Ju-Tao Guo. Front Microbiol 2019
62
22

LY6E impairs coronavirus fusion and confers immune control of viral disease.
Stephanie Pfaender, Katrina B Mar, Eleftherios Michailidis, Annika Kratzel, Ian N Boys, Philip V'kovski, Wenchun Fan, Jenna N Kelly, Dagny Hirt, Nadine Ebert,[...]. Nat Microbiol 2020
85
16

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
14

IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.
Courtney Wilkins, Jessica Woodward, Daryl T-Y Lau, Amy Barnes, Michael Joyce, Nicola McFarlane, Jane A McKeating, D Lorne Tyrrell, Michael Gale. Hepatology 2013
108
13

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.
Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu,[...]. Nat Commun 2013
178
13

Interferon-stimulated genes: a complex web of host defenses.
William M Schneider, Meike Dittmann Chevillotte, Charles M Rice. Annu Rev Immunol 2014
13

LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.
Katrina B Mar, Nicholas R Rinkenberger, Ian N Boys, Jennifer L Eitson, Matthew B McDougal, R Blake Richardson, John W Schoggins. Nat Commun 2018
62
20

A Novel Coronavirus from Patients with Pneumonia in China, 2019.
Na Zhu, Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song, Xiang Zhao, Baoying Huang, Weifeng Shi, Roujian Lu,[...]. N Engl J Med 2020
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.